ClinicalTrials.gg
Drug

Aspirin clinical trials

Also written Acetylsalicylic acid, Measurin, Adiro 100 and Durlaza.

studies test it
675
open now
119
in phase 3
154
first study started
1992

Counted the way a researcher would: Aspirin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Aspirin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Aspirin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Apr 1950 · PERCODAN · NDA 007337 (FDA, Drugs@FDA; in a combination)
European Union
14 Mar 2010 · DuoPlavin · EMEA/H/C/001143 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Aspirin
351
Aspirin 81 mg
21
Ecotrin
14
Low-dose aspirin
14
Aspirin 100mg
13

Brand

Measurin
8
Durlaza
2

Development codes

Adiro 100
3
ASA 81mg
1
ASA 325mg
1

Other names

Acetylsalicylic acid
111
ASA
50

In one entry with another drug

Given together, or one or the other

Aspirin and Clopidogrel
5
Aspirin + Clopidogrel
4
clopidogrel + aspirin
4
Dual antiplatelet treatment
3
Aspirin + Ticagrelor
3
Aspirin, Clopidogrel
3
Ticagrelor + Aspirin
2
Ticagrelor and Aspirin
2

Studies by the year they started

663 studies that test it; most in 2016 (39); 7 more planned to start later

Studies that test Aspirin, by start year
YearStudies
19922
19932
19971
19982
20002
20011
20028
200312
20049
200518
200615
200720
200826
200926
201028
201124
201227
201327
201434
201531
201639
201735
201827
201934
202039
202138
202229
202330
202428
202525
202624

By phase

A phase 1/2 study counts in both.

Early Phase 1
38
Phase 1
63
Phase 2
127
Phase 3
154
Phase 4
204
No phase
118

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 79 · Other 596

Bayer (19) · AstraZeneca (8) · National Cancer Institute (NCI) (7) · Medical University of Vienna (7) · Hamilton Health Sciences Corporation (7) · Vanderbilt University (7) · Massachusetts General Hospital (6) · University of Pennsylvania (6)

Often tested with

Tested in the same studies.

Clopidogrel (98) · Ticagrelor (32) · Rivaroxaban (26) · Atorvastatin (13) · Warfarin (10) · Enoxaparin (9) · Celecoxib (7) · Simvastatin (7)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 12 phase 3 studies under way

Aspirin is the comparator. A study of two new drugs counts under both.

  • 3Rivaroxaban · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Population Health Research Institute · next primary completion Sep 2027
  • 1Tenecteplase · The First Affiliated Hospital of Zhengzhou University · next primary completion Feb 2028
  • 1Cenvacibart · Regeneron Pharmaceuticals · next primary completion May 2027
  • 1Direct Oral Anticoagulant · University Hospital, Brest · next primary completion Jul 2027
  • 1Cilostazol · Zhejiang Provincial People's Hospital · next primary completion Aug 2031
  • 1Dabigatran · University of Zurich
  • 1Apixaban · University of Zurich
  • 1Edoxaban · University of Zurich
Reaching primary completion within a year · 48, 9 in phase 3

Studies that test Aspirin, phase 3 first.

Studies

Open first, then newest update. How each study uses Aspirin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 675

See all 675 studies that test Aspirin →

Given beside what is tested · 185 — Aspirin is usual care or a partner of the new treatment

Showing 20 of 185.

As the comparator · 145 — what is tested is compared with Aspirin

Showing 20 of 145.

Codes

What other systems call Aspirin · ClinicalTrials.gg INT007030

  • MeSH (NLM) D001241AspirinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) R16CO5Y76EASPIRINConfirmed FDA, NLM, Wikidata
  • RxNorm 1191Confirmed FDA, Wikidata
  • Wikidata Q18216aspirinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C287AspirinOne source FDA
  • DrugBank DB00945One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.